COGNITIVE IMPAIRMENT DETECTION IN ADULT THALASSEMIA PATIENT USING MOCA-INA
DOI:
https://doi.org/10.21776/ub.mnj.2021.007.01.6Keywords:
Cognitive function, MoCA-Ina, thalassemiaAbstract
Background: Cognitive impairment in thalassemia patients are prevalent, therefore early detection of cognitive impairment in adult thalassemia patients is crucial for prevention. Montreal Cognitive Assessment (MoCA) is a public domain cognition screening tools that covers all cognitive domains in detecting mild cognitive impairments.
Objective: To compare cognitive function between adult thalassemia patients and healty control by using Indonesia version of MoCA test (MoCA-Ina)
Methods: This prospective observational analytic with case control study, compared the total scores and scores of each domain of cognition between adult thalassemia patients and healthy subjects at the Medical Hematology Oncology Clinic of Dr. Hasan Sadikin General Hospital, Bandung, Indonesia using MoCA-Ina from August to October 2018.
Results: A total of 32 thalassemia subjects and 50 healthy subjects were conducted. A total of 16(50%) subjects in the case group had a value of MoCA-Ina <26, while only 1(2%) healthy control had a value of MoCA-Ina <26. The median total MoCA-Ina score in case and control groups were 25.5 and 27.50 (p <0.001). The median score of memory domains, executive functions and visuospatial of the case and control groups were 3 versus 4 (p <0.001), 3 versus 3.5 (p <0.001) and 3.53 ± 0.671 versus 3.88 ± 0.385 (p <0.003), respectively.
Conclusion: Adults thalassemia patients have lower score in total MoCA-Ina, domains of memory, executive function and visuospatial score compared to healthy control.
References
Zafeiriou DI, Economou M, Athanasiou-Metaxa M. Neurological complications in β-thalassemia. Brain Dev; 2006. 28(8):477–81.
DOI: 10.1016/j.braindev.2006.02.005
Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood; 2002. 99(1):36–43.
DOI: 10.3109/03630260903351619
Argyropoulou MI, Astrakas L. MRI evaluation of tissue iron burden in patients with β-thalassaemia major. Pediatr Radiol; 2007. 37(12):1191–200.
DOI: 10.1007/s00247-007-0567-1
Elliott EN, Kaestner KH. The Montreal Cognitive Assessment (MoCA): Creating a crosswalk with the Mini-Mental State Examination. J Geriatr Psychiatry Neurol; 2016. 72(21):4139–56. DOI:10.1111/jgs.13710
Trzepacz PT, Hochstetler H, Wang S, Walker B, Saykin AJ. Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults. BMC Geriatr; 2015. 15(1):1–9. DOI: 10.1186/s12877-015-0103-3
Santangelo G, Siciliano M, Pedone R, Vitale C, Falco F, Bisogno R, et al. Normative data for the Montreal Cognitive Assessment in an Italian population sample. Neurol Sci; 2015.36(4).
DOI: 10.1007/s10072-014-1995-y
Borland E, Nägga K, Nilsson PM, Minthon L, Nilsson ED, Palmqvist S. The Montreal Cognitive Assessment: Normative data from a Large Swedish Population-Based Cohort. J Alzheimer’s Dis; 2017. 59(3):893–901. DOI: 10.3233/JAD-170203
Husein N, Lumempouw S, Ramli Y, Herqutanto. Montreal Cognitive Assessment versi Indonesia (MoCA-Ina) untuk skrining gangguan fungsi kognitif. Neurona; 2010. 27(4). Available from: http://www.neurona.web.id/paper-detail.do?id=734
World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity [Internet]. Vitamin and Mineral Nutrition Information System. Geneva: World Health Organization; 2011. p. 1–6. Available from: https://www.who.int/vmnis/indicators/haemoglobin/en/
Gracia-Casal MN, Sant-Rayn P, Martinez RX, Lopez-Perez L, Peña-rosas JP. Serum or plasma ferritin concentration as an index of iron deficiency and overload (Protocol). Cochrane Database Syst Rev; 2015. (7). DOI: 10.1002/14651858.CD011817
World Health Organization. Serum ferritin concentrations for the assessment of iron status and iron deficiency in populations. World Health Organization. Geneva; 2011. p. 1–5. Available from: https://www.who.int/vmnis/indicators/serum_ferritin.pdf
Bernell S, Howard SW. Use Your Words Carefully: What Is a Chronic Disease? Front Public Heal; 2016. 4(August):2–4. DOI: 10.3389/fpubh.2016.00159
Joo SH, Yun SH, Kang DW, Hahn CT, Lim HK, Lee CU. Body mass index in mild cognitive impairment according to age, sex, cognitive intervention, and hypertension and risk of progression to Alzheimer’s disease. Front Psychiatry; 2018. 9(Apr):1–8.
DOI: 10.3389/fpsyt.2018.00142
Sungthong R, Mo-suwan L, Chongsuvivatwong V. Effects of haemoglobin and serum ferritin on cognitive function in school children. Asia Pac J Clin Nutr; 2002.11(2):117–22. DOI: 10.1046/j.1440-6047.2002.00272.x
Lambert A, Knaggs K, Scragg R, Metcalf P, Schaaf D. Effects of iron treatment on cognitive performance and working memory in non-anaemic , iron-deficient girls. NZ J Psychol; 2002. 31(1):19–28. Available from: https://www.researchgate.net/publication/283380250_Effects_of_iron_treatment_on_cognitive_performance_and_working_memory_in_non-anaemic_iron-deficient_girls
Maatook MA, Mohammed KA, Afat AM. The socio-demographic profile of thalassemia in Basrah. Med J Babylon; 2015.12(3):670–6.
DOI: 10.21474/IJAR01/7465
Trehan A, Sharma N, Das R, Bansal D, Marwaha RK. Clinicoinvestigational and demographic profile of children with thalassemia major. Indian J Hematol Blood Tranfus; 2015. 31(1):121–6. DOI: 10.1007/s12288-014-0388-y
Olivieri NF. The β- Thalassemias. N Engl J Med; 2014.341(2):99–109.
DOI: 10.1056/NEJM199907083410207
Elhabiby MM, ElSalakawy W, Khalil SA, Hassan DI, Hjislam SG. Cognitive dysfunction in β-thalassemia major and intermedia patients and its clinical correlates. Middle East Curr Psychiatry; 2016.23(3):128–33.
DOI: 10.1097/01.XME.0000484344.49943.1c
Amoudi AS, Balkhoyor AH, Abulaban AA, Azab AM, Radi SA, Ayoub MD, et al. Quality of life among adults with beta-thalassemia major in western Saudi Arabia. Saudi Med J; 2014. 35(8):882–5. Available from: https://pubmed.ncbi.nlm.nih.gov/25129193/
Vitrano A, Calvaruso G, Lai E, Colletta G, Quota A, Gerardi C, et al. The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major-intermedia dichotomy ? Br J Haematol; 2017. 176(October 2016):124–30. DOI: 10.1111/bjh.14381
Pakbaz Z, Treadwell M, Yamashita R, Quirolo K, Foote D, Quill L, et al. Quality of life in patients with thalassemia intermedia compared to thalassemia major. Ann N Y Acad Sci; 2005. 1054:457–61. DOI: 10.1196/annals.1345.059
Poggiali E, Cassinerio E, Zanaboni L, Cappellini MD. An update on iron chelation therapy. Blood Transfus; 2012.10:411–22. DOI 10.2450/2012.0008-12
Zamani R, Khazaei S. Survival Analysis and its Associated Factors of Beta Thalassemia Major in Hamadan Province. Iran J Med Sci; 2015. 40(3):233–9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430885/
Pakbaz Z, Treadwell M, Kim H-Y, Trachtenberg F, Parmar N, Kwiatkowski JL, et al. Education and employment status of children and adults with thalassemia in North America. Pediatr Blood Cancer; 2015.85(0 1):1–27.
DOI: 10.1002/pbc.22565
Wijaya LJ, Nency YM, Farida H. Faktor-faktor utama yang mempengaruhi prestasi belajar pasien talasemia mayor anak. J Kedokt Diponegoro; 2018.7(2):694–710. Available from: https://ejournal3.undip.ac.id/index.php/medico/article/view/20719
Aji DN, Silman C, Aryudi C, Andalia D, Astari D, Pitaloka DD, et al. Faktor–faktor yang berhubungan dengan kualitas hidup pasien thalassemia mayor di pusat thalassemia departemen ilmu kesehatan anak RSCM. Sari Pediatr; 2009.11(2):85–9. Available from: https://saripediatri.org/index.php/sari-pediatri/article/view/598
Shalitin S, Carmi D, Weintrob N, Phillip M, Miskin H, Kornreich L, et al. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients. Eur J Haematol; 2005. 74(2):93–100. DOI: 10.1111/j.1600-0609.2004.00371.x
Karamifar H, Shahriari M, Amirhakimi G. Linear growth deficiency in β-thalassemia patients: Is it growth hormone dependent? Iran J Med Sci; 2002.27(2):47–50. Available from: https://ijms.sums.ac.ir/article_40243.html
Prakash A, Aggarwal R. Thalassemia major in adults: Short stature, hyperpigmentation, inadequate chelation, and transfusion-transmitted infections are key features. N Am J Med Sci; 2012.4(3):141–4. DOI: 10.4103/1947-2714.93886
Arimbawa M, Ketut A. Profil Pertumbuhan, hemoglobin pre-transfusi, kadar feritin, dan usia tulang anak pada thalassemia mayor. Sari Pediatr; 2011.13(4):299–304. Available from: https://saripediatri.org/index.php/sari-pediatri/article/view/428
Monastero R, Monastero G, Ciaccio C, Padovani A, Camarda R. Cognitive deficits in beta-thalassemia major. Acta Neurol Scand; 2000.102(3):162–8. DOI: 10.1034/j.1600-0404.2000.102003162.x
Lestari LPMD. Pengaruh memori kerja terhadap performa sekolah sebagai salah satu aspek kualitas hidup anak penyandang talasemia beta mayor usia 8-12 tahun. Universitas Padjadjaran; 2016.
Raafat N, El Safy U, Khater N, Hassan T, Hassan B, Siam A, et al. Assessment of cognitive function in children with beta-thalassemia major: a cross-sectional study; J Child Neurol. 2015.30(4):417–22. DOI: 10.1177/0883073814550827
Schneider ALC, Jonassaint C, Sharrett R, Mosley TH, Astor BC, Selvin E, et al. Hemoglobin, anemia, and cognitive function: The atherosclerosis risk in communities study. Journals Gerontol Med Sci; 2016.71(6):772–9. DOI: 10.1093/gerona/glv158
Mackin RS, Insel P, Truran D, Vichinsky EP, Neumayr LD, Armstrong FD, et al. Neuroimaging abnormalities in adults with sickle cell anemia Associations with cognition. Neurology; 2014.82:835–41. DOI: 10.1212/WNL.0000000000000188
Rehncrona S, Hauge HN, Siesjo BK. Enhancement of iron-catalyzed free radical formation by acidosis in brain homogenates: Difference in effect by lactic acid and CO2. J Cereb Blood Flow Metab; 1989.9(1):65–70. DOI: 10.1038/jcbfm.1989.9
Akhlaghpoor S, Ghahari A, Morteza A, Khalilzadeh O, Shakourirad A, Alinaghizadeh MR. Quantitative T2* magnetic resonance imaging for evaluation of iron deposition in the brain of β-thalassemia patients. Clin Neuroradiol; 2012. 22(3):211–7.
DOI: 10.1007/s00062-011-0108-z
Lam WWM, Au WY, Chu WCW, Tam S, Ha SY, Pennell DJ. One-stop measurement of iron deposition in the anterior pituitary, liver, and heart in thalassemia patients. J Magn Reson Imaging; 2008. 28(1):29–33. DOI: 10.1002/jmri.21433
Nyberg F. The Role of the Somatotrophic Axis in Neuroprotection and Neuroregeneration of the Addictive Brain [Internet]. 1st ed. Vol. 88, International Review of Neurobiology. Elsevier Inc; 2009. 399–427 p. DOI: 10.1016/S0074-7742(09)88014-8
Aberg ND. Role of the Growth Hormone/Insulin-Like Growth Factor 1 Axis in Neurogenesis. Pediatr Neuroendocrinol; 2010.17:63–76. DOI:10.1159/000262529
Bliss TVP, Cooke SF. Long-term potentiation and long-term depression: a clinical perspective. Clinics; 2011. 66(S1):3–17. DOI: 10.1590/S1807-59322011001300002
Nyberg F. Growth hormone in the brain: Characteristics of specific brain targets for the hormone and their functional significance. Front Neuroendocrinol; 2000. 21(4):330–48.
DOI: 10.1006/frne.2000.0200
Kenney JW, Gould TJ. Modulation of Hippocampus-Dependent Learning and Synaptic Plasticity by Nicotine. Mol Neurobiol; 2008.38(1):101–21. DOI: 10.1007/s12035-008-8037-9
Yacobovich J, Tamary H. Thalassemia major and sickle cell disease in adolescents and young adults. Acta Haematol; 2014.132(3–4):340–7.
DOI: 10.1159/000360235
Malik S, Syed S, Ahmed N. Complications in transfusion-dependent patients of B-thalassemia major: A review. Pakistan J Med Sci; 2009.25(4):678–82. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767285/
Estrella Castillo DF, Nemegyei JA, de Regil LG. Association between body mass index with cognitive or physical functioning, and depression in Mexican elderly: A cross-sectional study. Neuropsychiatry (London); 2016.6(5):271–9.
DOI: 10.4172/Neuropsychiatry.1000149
Suemoto CK, Gilsanz P, Mayeda ER, Glymour MM. Body mass index and cognitive function: the potential for reverse causation. Int J Obes (Lond); 2015. Sep;39(9):1383-9. DOI: 10.1038/ijo.2015.83
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Malang Neurology Journal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
